Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours
…, D Thamm, ML Higginbotham… - Veterinary and …, 2012 - Wiley Online Library
The purpose of this study was to provide an initial assessment of the potential biologic activity
of toceranib phosphate (Palladia®, Pfizer Animal Health, Madison, NJ, USA) in select solid …
of toceranib phosphate (Palladia®, Pfizer Animal Health, Madison, NJ, USA) in select solid …
Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma
…, L Jorgensen, MA Scott, ML Higginbotham… - Clinical Cancer …, 2003 - AACR
Purpose: Cyclooxygenase inhibitors show promise in chemoprevention andtherapy of certain
carcinomas, an effect that may be additiveto that of standard chemotherapy. The purpose …
carcinomas, an effect that may be additiveto that of standard chemotherapy. The purpose …
Immunophenotypic and histologic classification of 50 cases of feline gastrointestinal lymphoma
LM Pohlman, ML Higginbotham… - Veterinary …, 2009 - journals.sagepub.com
The purpose of this study was to determine the immunophenotype and histologic classification
of 50 cases of feline gastrointestinal lymphoma. Classification was determined using the …
of 50 cases of feline gastrointestinal lymphoma. Classification was determined using the …
Adjuvant sirolimus does not improve outcome in pet dogs receiving standard-of-care therapy for appendicular osteosarcoma: a prospective, randomized trial of 324 …
…, AN Smith, N Dervisis, S Klahn, ML Higginbotham… - Clinical Cancer …, 2021 - AACR
Purpose: The mTOR pathway has been identified as a key nutrient signaling hub that participates
in metastatic progression of high-grade osteosarcoma. Inhibition of mTOR signaling is …
in metastatic progression of high-grade osteosarcoma. Inhibition of mTOR signaling is …
[BOOK][B] Cancer Management in Small Animal Practice-E-Book: Cancer Management in Small Animal Practice-E-Book
CJ Henry, ML Higginbotham - 2009 - books.google.com
… During the past year of development, my coeditor, Mary Lynn Higginbotham, and I were told
that this could no longer be called a “handbook” because that would falsely imply it would fit …
that this could no longer be called a “handbook” because that would falsely imply it would fit …
Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs
…, DL McCaw, ML Higginbotham… - American journal of …, 2003 - Am Vet Med Assoc
Objective —To evaluate the veterinary version of the bladder tumor antigen (V-BTA) test as
a screening test for transitional cell carcinoma (TCC) of the lower urinary tract of dogs. …
a screening test for transitional cell carcinoma (TCC) of the lower urinary tract of dogs. …
Occurrence and clinicopathologic features of splenic neoplasia based on body weight: 325 dogs (2003–2013)
…, E Klocke, ML Higginbotham… - Journal of the …, 2016 - meridian.allenpress.com
Medical records of 396 dogs undergoing splenectomy for treatment of a splenic mass or
nodular disease were reviewed retrospectively. Overall distribution of histopathologic diagnosis …
nodular disease were reviewed retrospectively. Overall distribution of histopathologic diagnosis …
Development and validation of a hemangiosarcoma likelihood prediction model in dogs presenting with spontaneous hemoabdomen: the HeLP score
…, KG Mathews, ML Higginbotham… - Journal of veterinary …, 2019 - Wiley Online Library
Objective To calculate a risk prediction model for hemangiosarcoma (HSA) diagnosis in
dogs presenting with nontraumatic hemoabdomen. Design Retrospective multicenter …
dogs presenting with nontraumatic hemoabdomen. Design Retrospective multicenter …
Evaluation of a novel immunomodulator composed of human chorionic gonadotropin and bacillus Calmette-Guerin for treatment of canine mast cell tumors in clinically …
…, DL McCaw, ML Higginbotham… - American journal of …, 2007 - Am Vet Med Assoc
Objective —To evaluate safety and efficacy of LDI-100, a preparation containing human
chorionic gonadotropin (hCG) and bacillus Calmette-Guerin (BCG), in the treatment of dogs with …
chorionic gonadotropin (hCG) and bacillus Calmette-Guerin (BCG), in the treatment of dogs with …
Intermittent single-agent doxorubicin for the treatment of canine B-cell lymphoma
ML Higginbotham, DL McCaw… - Journal of the …, 2013 - meridian.allenpress.com
Canine B-cell lymphoma is a highly treatable disease, but cost and logistical factors may
hamper an owner’s ability to pursue treatment of their pet with this disease. The authors …
hamper an owner’s ability to pursue treatment of their pet with this disease. The authors …